Fujie Zhang

Summary

Affiliation: Chinese Center for Disease Control and Prevention
Country: China

Publications

  1. doi request reprint Therapeutic drug monitoring in highly active antiretroviral therapy
    Xia Liu
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nan Wei Road, Beijing 100050, China
    Expert Opin Drug Saf 9:743-58. 2010
  2. ncbi request reprint Five-year outcomes of the China National Free Antiretroviral Treatment Program
    Fujie Zhang
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    Ann Intern Med 151:241-51, W-52. 2009
  3. pmc The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China
    Fujie Zhang
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Ditan Hospital, Beijing, China
    Clin Infect Dis 47:825-33. 2008
  4. doi request reprint The Chinese free antiretroviral treatment program: challenges and responses
    Fujie Zhang
    National Center for AIDS STD Control and Prevention Chinese Center for Disease Control and Prevention, Beijing, China
    AIDS 21:S143-8. 2007
  5. ncbi request reprint Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes
    Fujie Zhang
    Chinese Center for Disease Control and Prevention, National Center for AIDS, Division of Treatment and Care, Beijing, China
    J Acquir Immune Defic Syndr 46:594-8. 2007
  6. ncbi request reprint Overview of HIV drug resistance and its implications for China
    Fu Jie Zhang
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    Chin Med J (Engl) 119:1999-2004. 2006
  7. pmc Recent key advances in human immunodeficiency virus medicine and implications for China
    Kai Sun
    School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
    AIDS Res Ther 7:12. 2010
  8. doi request reprint Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohort
    Yao Zhang
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
    J Acquir Immune Defic Syndr 60:59-67. 2012
  9. doi request reprint Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study
    Fujie Zhang
    Division of Treatment and Care, National Centre for AIDS STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
    Lancet Infect Dis 11:516-24. 2011
  10. pmc Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008
    Zhihui Dou
    Chinese Center for Disease Control and Prevention, Beijing, China
    PLoS ONE 6:e22707. 2011

Collaborators

Detail Information

Publications27

  1. doi request reprint Therapeutic drug monitoring in highly active antiretroviral therapy
    Xia Liu
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nan Wei Road, Beijing 100050, China
    Expert Opin Drug Saf 9:743-58. 2010
    ..Therapeutic drug monitoring (TDM) has been utilised to improve treatment outcomes of ART...
  2. ncbi request reprint Five-year outcomes of the China National Free Antiretroviral Treatment Program
    Fujie Zhang
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    Ann Intern Med 151:241-51, W-52. 2009
    ..China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients...
  3. pmc The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China
    Fujie Zhang
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Ditan Hospital, Beijing, China
    Clin Infect Dis 47:825-33. 2008
    ..Highly active antiretroviral therapy (HAART) was provided for former plasma donors beginning in 2002. The effect of HAART on mortality in this cohort has not been described...
  4. doi request reprint The Chinese free antiretroviral treatment program: challenges and responses
    Fujie Zhang
    National Center for AIDS STD Control and Prevention Chinese Center for Disease Control and Prevention, Beijing, China
    AIDS 21:S143-8. 2007
    ..The Free ART Program has made considerable progress in providing the necessary care and treatment for HIV-infected people in China and has strong government support for continued improvement and expansion...
  5. ncbi request reprint Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes
    Fujie Zhang
    Chinese Center for Disease Control and Prevention, National Center for AIDS, Division of Treatment and Care, Beijing, China
    J Acquir Immune Defic Syndr 46:594-8. 2007
    ..Few data are available on the outcomes of pediatric antiretroviral therapy (ART) in the developing world...
  6. ncbi request reprint Overview of HIV drug resistance and its implications for China
    Fu Jie Zhang
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    Chin Med J (Engl) 119:1999-2004. 2006
  7. pmc Recent key advances in human immunodeficiency virus medicine and implications for China
    Kai Sun
    School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
    AIDS Res Ther 7:12. 2010
    ..Lastly, we review important achievements of and future challenges facing China as she steps into her eighth year of the National Free Antiretroviral Treatment Program...
  8. doi request reprint Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohort
    Yao Zhang
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
    J Acquir Immune Defic Syndr 60:59-67. 2012
    ..However, few studies have evaluated indicators for patient access to medical care and their association with mortality...
  9. doi request reprint Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study
    Fujie Zhang
    Division of Treatment and Care, National Centre for AIDS STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
    Lancet Infect Dis 11:516-24. 2011
    ..Overall HIV mortality rates in China have not been reported. In this analysis we assess overall mortality in treatment-eligible adults with HIV and attempt to identify risk factors for HIV-related mortality...
  10. pmc Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008
    Zhihui Dou
    Chinese Center for Disease Control and Prevention, Beijing, China
    PLoS ONE 6:e22707. 2011
    ..Gender differences, however, in mortality and immunological response to ART in this cohort have never been described...
  11. pmc Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy program
    Yan Zhao
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
    Clin Infect Dis 56:735-44. 2013
    ..The aim of this study was to describe 3-year mortality rates, associated risk factors, and long-term clinical outcomes of children enrolled in China's national free pediatric antiretroviral therapy (ART) program...
  12. pmc Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09
    Zhihui Dou
    Chinese Center for Disease Control and Prevention, Beijing, People s Republic of China
    Int J Epidemiol 39:ii56-64. 2010
    ..To improve HIV treatment in China by determining changes over time of patient characteristics (geographic, clinical and route of HIV infection) among patients enrolled in the China National Free Antiretroviral Treatment Program...
  13. pmc Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China
    Ye Ma
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, US Embassy, Beijing, China
    Clin Infect Dis 50:264-71. 2010
    ..Despite poor primary health care systems, free antiretroviral therapy (ART) has been available in China for >5 years. Virologic outcomes in Chinese patients receiving ART have not been described on a national level...
  14. doi request reprint Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008
    Ye Ma
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    Clin Infect Dis 54:S300-2. 2012
    ..HIV drug resistance early warning indicator monitoring provides a valuable assessment of ART service delivery, and its application will be scaled up throughout China...
  15. doi request reprint Progress of the National Pediatric Free Antiretroviral Therapy program in China
    Yan Zhao
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Xuan Wu District, China
    AIDS Care 22:1182-8. 2010
    ..Secondly, much of the pediatric ARV drug supply depends on donation. An effort needs to be made by the Chinese Government to establish China's own drug procurement and supply system...
  16. ncbi request reprint The diagnosis and treatment of HIV-infected children in China: challenges and opportunities
    Fujie Zhang
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control, Beijing, People s Republic of China
    J Acquir Immune Defic Syndr 44:429-34. 2007
    ..This national survey describes the demographic characteristics and the associated diagnostic and antiretroviral treatment (ART) efforts directed toward surviving HIV-infected children...
  17. ncbi request reprint CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients
    Junyan Han
    Institute of Infectious Diseases, Capital Medical University, Beijing, China
    J Acquir Immune Defic Syndr 52:553-9. 2009
    ..Because CD14(+)CD16(+) monocytes are a heterogeneous population and consist of CD14(high)CD16(+) and CD14(low)CD16(+) subsets, we evaluated the effects of HIV infection on distinct subsets of CD16(+) monocytes...
  18. pmc Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009
    Shuntai Zhou
    Division of Treatment and Care, National Center for AIDS STI Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    J Acquir Immune Defic Syndr 54:191-6. 2010
    ..In this study, we evaluated the seroprevalence of HBV and HCV in children receiving ART and associated factors...
  19. pmc HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008
    Zhihui Dou
    Chinese Center for Disease Control and Prevention, Beijing, China
    PLoS ONE 5:e13737. 2010
    ..The objectives of this study are to estimate the timing and geographic spread of HIV infection in this cohort and to demonstrate the impact of antiretroviral therapy on survival outcomes...
  20. pmc Quantitatively monitoring AIDS policy implementation in China
    Yufen Liu
    Chinese Center for Disease Control and Prevention, Beijing, China
    Int J Epidemiol 39:ii90-6. 2010
    ..We tested a hypothesis that incrementally setting realistic quantitative targets for key indicators and monitoring performance would facilitate AIDS policy implementation in China...
  21. pmc Decreasing Excess Mortality of HIV-Infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003-2009
    Hao Zhu
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC and Division of Infectious Diseases, Beijing Ditan Hospital Capital Medical University, Beijing, China
    J Acquir Immune Defic Syndr 63:e150-7. 2013
    ..To evaluate excess mortality across calendar time comparing HIV-infected patients receiving combination antiretroviral therapy (cART) with the general Chinese population...
  22. doi request reprint Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China
    Yan Zhao
    Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
    J Acquir Immune Defic Syndr 58:47-53. 2011
    ....
  23. doi request reprint Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts
    Haiwei Zhou
    Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China
    AIDS 27:1059-69. 2013
    ..We investigated the effects of HIV infection and HAART on distinct Treg subsets...
  24. pmc Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
    Yan Zhao
    National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, China
    Bull World Health Organ 91:93-101. 2013
    ..To examine the effect of methadone maintenance treatment (MMT) on mortality in people injecting opioids who receive antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection in China...
  25. pmc Estimating the number of people living with HIV/AIDS in China: 2003-09
    Ning Wang
    Chinese Center for Disease Control and Prevention, Beijing, China
    Int J Epidemiol 39:ii21-8. 2010
    ..Subsequent national estimation exercises were carried out in 2005, 2007 and 2009. We describe these estimation processes and present the results of China's HIV/AIDS estimation exercises from 2003 to 2009...
  26. pmc Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort
    Kai Liu
    Department of Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China Beijing Institute of Hepatology, Beijing, China
    PLoS ONE 8:e57223. 2013
    ..These results suggest that mitochondrial toxicity occurs in long-term HAART patients and that P53R2 and TK2 levels in PBMCs are useful biomarkers for detecting mitochondrial toxicity in patients on long-term treatment with NRTIs...
  27. ncbi request reprint [A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection]
    Yunzhen Cao
    Laboratory of Clinical Virology, AIDS Prevention and Control Center, Ministry of Health, Beijing 100050, China
    Zhonghua Nei Ke Za Zhi 41:109-13. 2002
    ..Evaluation of high active antiretroviral therapy (HAART) in human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) patients receiving combined antiretroviral therapy in China...